Inivata is a Leader

in Liquid Biopsy
Unlocking essential genomic information from a simple
blood draw to transform the care of cancer patients
InVisionFirst Lung - Liquid Biopsy Solutions

Our InVision® platform unlocks essential genomic information from a simple blood draw to transform the care of cancer patients

InVision First logo

Our US Medicare-reimbursed lead product InVisionFirst-Lung is already transforming the lives of advanced NSCLC patients

Our Mission

We are transforming the lives of cancer patients and their families through the power of liquid biopsy

InvisionFirst Lung - ctDNA Liquid Biopsy Test

Our Technology - Liquid Biopsy Testing

Our Technology

Contact Us at Inivata

Contact Us

Latest News and Events

Inivata’s Nitzan Rosenfeld to Receive 2020 Cancer Researcher Award from the European Association for Cancer Research and Pezcoller Foundation

Research Triangle Park, NC, USA and Cambridge, UK, February 27, 2020 – Inivata, a leader in liquid biopsy, is pleased to announce that ... Read More

Circulating tumor DNA analysis for patients with oncogene-addicted NSCLC with isolated central nervous system progression

Mihaela Aldea MD, PhD, Lizza Hendriks MD, PhD, Laura Mezquita MD, PhD, Cécile Jovelet PharmD, PhD, David Planchard MD, PhD, Edouard ... Read More

2020 ASCO Annual Meeting

2020 ASCO Annual Meeting

Event expiration date display - 29 MAY - 2 JUN 2020

Location: Chicago Read More

Changing Lives

Patients are at the heart of everything we do.

Our first product is for advanced Non-Small Cell lung Cancer and our world-leading tests are already impacting patients’ lives. 

This is the story of the first patient Inivata tested.

Transforming the lives of Cancer Patients and Their Families

As a dynamic and innovative company, we focus on the development of ground-breaking technology in a fast-paced and international setting.

Our team of talented and driven individuals work together to combine their energy and expertise in world-class research, product development and commercialization. Join us.

On #WorldHealthDay we would like to recognise the hard work done by all healthcare professionals during this global crisis and always. #ThanksHealthHeroes 🙏

Register for our WEBINAR - How Residual Disease and Recurrence (RDR) Testing using #LiquidBiopsy is Changing Clinical Trial Design with Nitzan Rosenfeld PhD.
15th and 29th April 10EST Find our more here
#residualdisease #oncology #inivata #ctDNA

WEBINAR with Nitzan Rosenfeld, PhD - How Residual Disease and Recurrence (RDR) Testing using Liquid Biopsy is Changing Clinical Trial Design. Find out more and register here